Strongbridge Biopharma plc

📍 US location- Trevose, United States🗓 Founded 1996👥 85 employees💰 Last funded Oct 2014
Biotechnology🌐 strongbridgebio.com
Website LinkedIn
Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. We are called Strongbridge for a reason. Our name reflects the collective strength of our rare disease expertise, our product portfolio and pipeline, and our patient-driven culture—one that is fueled by performance, precision and heart. Together, we are working to remove the barriers and isolation associated with rare neuromuscular and endocrine diseases in order to connect patients with the life-enhancing treatment options they deserve. Strongbridge is incorporated in Ireland, and its U.S. headquarters are located just outside of Philadelphia, PA. Strongbridge Biopharma is publicly traded on the NASDAQ Global Market under the ticker symbol SBBP. Rare Focus. Rare Commitment. Rare Passion. That’s Strongbridge.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1996
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Strongbridge Biopharma plc?
Strongbridge Biopharma plc has 1 investors on record on gritt.io.
When did Strongbridge Biopharma plc last raise funding?
The most recent investment in Strongbridge Biopharma plc recorded on gritt.io was in October 2014.
When was Strongbridge Biopharma plc founded?
Strongbridge Biopharma plc was founded in 1996.
What industry is Strongbridge Biopharma plc in?
Strongbridge Biopharma plc operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Strongbridge Biopharma plc based?
Strongbridge Biopharma plc is headquartered in US location- Trevose, United States.